# Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease

> **NCT00657527** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 280 (estimated)

## Conditions studied

- Myocardial Ischaemia
- Coronary Artery Disease

## Interventions

- **DRUG:** Rosuvastatin
- **BEHAVIORAL:** Cholesterol lowering diet

## Key facts

- **NCT ID:** NCT00657527
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** —
- **Final completion:** 2002-12
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2009-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00657527

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00657527, "Evaluation of Effects of Rosuvastatin 40mg on Myocardial Ischemia in Subjects With Coronary Artery Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00657527. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*